ML21278B103

From kanterella
Jump to navigation Jump to search
Transcript - Fda and NRC Workshop on Enhancing Development of Targeted Alpha-Emitting Radiopharmaceuticals, Special Session on Actinium-225
ML21278B103
Person / Time
Issue date: 09/22/2021
From:
NRC/NMSS/DMSST/MSEB
To:
Sarah Lopas
References
NRC-1654
Download: ML21278B103 (249)


Text